iCancer is inviting applications for editorial board members
The journal is building an international editorial team across clinical oncology, cancer biology, translational research, biomedical data science, and cancer health services.
iCancer publishes rigorous open-access oncology research across discovery biology, translational medicine, clinical oncology, precision medicine, artificial intelligence, epidemiology, and cancer care delivery.
iCancer welcomes original research, reviews, systematic reviews, brief reports, perspectives, methods, and resources that advance cancer research or clinical oncology practice.
The journal is building an international editorial team across clinical oncology, cancer biology, translational research, biomedical data science, and cancer health services.
The article feed will list titles, authors, abstracts, full text, PDF links, references, and permissions information as articles are published.
Authors should prepare manuscripts according to the journal's reporting, ethics, data, AI disclosure, and metadata requirements.
The first issue cover frames the tumor immune microenvironment as a disease fortress, connecting immune regulation, integrative multi-omics analysis, and precision oncology.